medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2009, Number 3

<< Back Next >>

Rev Invest Clin 2009; 61 (3)

Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats

García-González A, Lotz M, Ochoa JL

Language: English
References: 30
Page: 212-220
PDF size: 127.26 Kb.


ABSTRACT

Introduction. Rheumatoid arthritis is an autoimmune inflammatory disease of unknown etiology, free radicals have been implicated in the genesis and perpetuation of damage in this pathology. Objective. To evaluate the anti-inflammatory effect of Cu,Zn-superoxide dismutase (SOD) obtained from two different sources (bovine erythrocytes, Be-SOD, and Debaryomyces hansenii, Dh-SOD) with Type II Collagen-induced Arthritis model in rats. Material and methods. Arthritis was induced by repeated injection of a porcine type II collagen-incomplete Freund adjuvant suspension on the back of Dark Augui (DA) rats. Arthritis was clinically evaluated throughout the study. Body weight was determined at three different times. Two different doses for each treatment (Be-SOD, Dh-SOD) were tested: 100 and 1,000 U/kg. At the end of the trial (day 28), histological analyses of the most inflamed ankle joint, as well as serum anticollagen antibodies, were determined. Results. Both sources of SOD decreased, although to a different extent, the incidence and severity of the disease. Arthritis score was lower in all treatments, except for the low dose of Be-SOD. Groups receiving either source of SOD showed a significant weight increase compared to the placebo group. Histological damage was similar in all groups. Only the group that received the highest dose of Dh-SOD showed a significant lower antibody titer; nevertheless, no correlation appears to derive from arthritis score and antibody titer. Conclusions. Our findings suggest that, although unable to counteract the arthritis syndrome, SOD may still be beneficial due to its anti-inflammatory activity. In the case of Dh-SOD, the best effect was observed at the highest dose tested.


REFERENCES

  1. Harris EDJr. Mechanisms of disease: rheumatoid arthritis-pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277-89.

  2. Mitchel DM. Epidemiology. In: Utzinger PD, Zvaifler NJ, Ehrlich GE (eds.). Rheumatoid Arthritis, Etiology, Diagnosis, Management. Philadelphia: JB Lippincott Co; 1985, p. 133-50.

  3. Andriopolous NA, Bennett JC, Mestecky J, et al. The occurrence of antibodies against human collagen in synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 1975; 18: 384-90.

  4. Trentham DE, Towens AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977; 146: 857-68.

  5. Trentham DE, Towens AS, Kang AH, David JR. Humoral and cellular sensitivity to collagen in type II collagen induced arthritis in rats. J Clin Invest 1978; 61: 89-96.

  6. Cannon GW, Openshaw SJ, Hibbs JB, et al. Nitric oxide production during adjuvant induced and collagen induced arthritis. Arthritis Rheum 1996; 39: 1677-84.

  7. Griffiths MM, Eichwald EJ, Martin JH, et al. Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum 1981; 24: 781-9.

  8. Sloboda AE, Birnbaunm JE, Oronsky AL, Kerwar SS. Studies on type II collagen-induced polyarthritis in rats. Effect of antiinflammatory and antirheumatic agents. Arthritis Rheum 1981; 24: 616-24.

  9. McCord JM. Mechanisms of disease. Oxygen derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.

  10. Cross CE. Davis conference. Oxygen radicals and human disease. Ann Inter Med 1987; 107: 526-45.

  11. Greenwald RA. Oxygen radicals, inflammation, and arthritis: Pathophysiological considerations and implications for treatment. Sem Arthr Rheum 1991; 20: 219-40.

  12. Reilly PM, Schiller HJ, Buckley G. Pharmacology approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surgery 1991; 161: 488-503.

  13. Ochoa JL, Ramirez-Orozco M, Hernandez-Saavedra NY, Hernandez- Saavedra D. Halotolerant yeast Debaryomyces hansenii as an alternative source of Cu/Zn superoxide dismutase (SOD). J Marine Biotech 1995; 3: 224-7.

  14. Hernandez-Saavedra NY, Ochoa JL. Copper-Zinc superoxide dismutase from the marine yeast Debaryomyces hansenii. Yeast 1999; 15: 657-68.

  15. Kakimoto K, Kojima Y, Ishii K, et al. The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen induced arthritis in mice. Clin Exp Immunol 1993; 94: 241-6.

  16. Beauchamp C, Gilbertsen RB, Fantone J, Menapace DP. Disease modifying activity of superoxide dismutase in collagen induced arthritis in the rat. FASEB 1983 Abstracts 67th annual meeting 6354.

  17. Hunt DW, Corson L, Braker H, et al. Relationship between collagen- induced and adjuvant arthritis in the Lewis rat. J Autoimm 1993; 6: 691-700.

  18. Courtenay JS, Dallman MJ, Dayan SD, et al. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980; 283: 666-8.

  19. Cooper WO, Fava RA, Gates CA, et al. Acceleration of onset of collagen induced arthritis by intra-articular injection of tumor necrosis factor or transforming growth factor beta. Clin Exp Immunol 1992; 89: 244-50.

  20. Larsson P, Kleinau S, Holmdahl R, et al. Homologous type II collagen induced arthritis in rats. Arthritis Rheum 1990; 33: 693-701.

  21. Durie FH, Fava RA, Noelle RJ. Collagen induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol 1994; 73: 11-8.

  22. Smith SR, Pennline KJ, Bober LA, et al. Inhibition of collagen II induced arthritis in mice. A comparison effects of SCH 24937, immunosuppressant, and non-steroideal anti-inflammatory drugs on clinical expression of disease. Int J Immunopharmac 1990; 12: 165-73.

  23. Sato K, Akaike T, Kohno M, et al. Hydroxyl radical production by H2O2 plus Cu,Zn superoxide dismutase reflects the activity of free copper released from oxidatively damaged enzyme. J Biol Chem 1992; 267: 25371-7.

  24. Jasin HE, Noyori K, Tagaki T, et al. Characterization of antitype II collagen antibodies binding to articular cartilage. Arthritis Rheum 1993; 36: 651-9.

  25. Greenwald RA. Oxygen radicals, inflammation and arthritis: pathophysiological considerations and implications for treatment. Sem Arthr Rheum 1991; 20: 219-40.

  26. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Rad Biol Med 1997; 22: 269-85.

  27. Oyanagui Y. Steroid-like anti-inflammatory effect of superoxide dismutase in serotonin-, histamine-, and kinin-induced edemata of mice: existence of vascular permeability regulating protein(s). Biochem Pharmacol 1981; 30: 1791-8.

  28. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004; 6: 265-78.

  29. Hayashi M, Matsunaga K, Okahara A, et al. Effect of bucillamine (SA96) on type II collagen induced arthritis in rats. J Rheumatol 1991; 18: 691-5.

  30. Das UN. Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases. Prostaglandins Leukotrienes Fatty Acids 1991; 44: 201-10.




2020     |     www.medigraphic.com